Dr. Manas Vaishnav

Dr Manas Vaishnav

MD Medicine (BJMC, Ahmedabad)
DM Gastroenterology (AIIMS, Delhi)
Fellowship in Hepatology (AIIMS, Delhi)

Dr Manas Vaishnav is young Best Gastroenterologist and Hepatologist in Ahmedabad who is dedicated and skilled in diagnosing and treating disease related to gastrointestinal tract, liver, and pancreas. He has done his MBBS and MD (Medicine) from B. J. Medical College, Ahmedabad. He has been trained at prestigious All India Institute of Medical Sciences (AIIMS), New Delhi which is considered as one of the best academic institutes in India where he did DM Gastroenterology. He is having special interest in liver disease and has done Fellowship in Hepatology from All India Institute of Medical Sciences (AIIMS) New Delhi. He was awarded Dr Rakesh Tandon book prize for best AIIMS Delhi DM student in year 2022.

He is proficient in diagnosing and treating a wide range of gastrointestinal and liver disorder including complex cases. Being trained at high volume centre, he is experienced in performing various diagnostic as well as therapeutic procedures including UGI endoscopy, Colonoscopy, ERCP, EUS, Cholangioscopy, Manometry, pH study and capsule endoscopy. He is also trained in managing complex liver disease case including pre and post liver transplant patients, liver cancer and acute on chronic liver failure. He is expert in managing post Liver Transplant biliary complications including post-transplant ERCP and biliary stenting.

He has keen interest in research and has more than 30 publications in indexed journals with more than 250 citations. He has strong interpersonal skills and ability to communicate effectively with patients. He is committed to evidence- based medicine and continuous professional development.

Professional affiliations
  • Member of Indian Society of Gastroenterology (ISG)
  • Member of European Association for the study of the Liver (EASL)
  • Member of Indian National Association for Study of the Liver (INASL)
Research and Publications
  • 1. Endoscopic Glue Injection vs Glue Plus BRTO or TIPSS for Preventing Gastric Variceal Bleeding: A Randomized Controlled Trial. Biswas S, Vaishnav M, Gamanagatti S, et al. Clinical Gastroenterology and Hepatology 2024; https://doi.org/10.1016/j.cgh.2024.06.023
  • Thromboelastography-guided vs. standard-of-care or on-demand platelet transfusion in patients with cirrhosis and thrombocytopenia undergoing procedures: A randomized controlled trial. Biswas S, Anand A, Vaishnav M, et al. Journal of Vascular and Interventional Radiology 2024; https://doi.org/10.1016/j.jvir.2024.06.014
  • Comparison of 1‐day versus 3‐day intravenous terlipressin in cirrhosis patients with variceal bleeding: A pilot randomised controlled trial. Vaishnav M, Biswas S, Shenoy A, et al. Aliment Pharmacol Ther 2024;59(5):645–55. https://doi.org/10.1111/apt.17868
  • Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis. Swaroop S, Vaishnav M, Arora U, et al. Journal of Clinical and Experimental Hepatology 2024;14(2):101291. https://doi.org/10.1016/j.jceh.2023.10.002
  • Definitions, Etiologies, and Outcomes of Acute on Chronic Liver Failure: A Systematic Review and Meta-analysis. Aggarwal A, Biswas S, Arora U, Vaishnav M et al. Clinical Gastroenterology and Hepatology 2024;S1542356524004257. https://doi.org/10.1016/j.cgh.2024.04.018
  • Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding. Vaishnav M, Biswas S, Anand A, et al. Diagnostics 2023;13(14):2385. http://dx.doi.org/10.3390/diagnostics13142385
  • Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease. Biswas S, Vaishnav M, Farooqui N, et al. Postgraduate Medical Journal http://dx.doi.org/10.1093/postmj/qgad035
  • The Outcome in Cirrhosis after Hospital Discharge is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. Vaishnav M, Elhence A, Biswas S, et al. J Clin Exp Hepatol 2022;12(3):830–40. https://doi.org/10.1016/j.jceh.2021.11.009
  • Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease. Biswas S, Vaishnav M, Pathak P, et al. World J Hepatol 2022;14(7):1421–37 http://dx.doi.org/10.4254/wjh.v14.i7.1421
  • 10. Pregnancy outcomes in patients with Budd–Chiari syndrome: A tertiary care experience. Biswas, S., Sheikh, S., Vaishnav, M. et al Indian Journal of Gastroenterology. https://doi.org/10.1007/s12664-022-01307-
  • 11. Predictors of in-hospital Outcomes in Patients with Cirrhosis and Coronavirus Disease-2019. Elhence A, Vaishnav M, Biswas S, et al. Journal of Clinical and Experimental Hepatology 2022;12(3):876–86. https://doi.org/10.1016%2Fj.jceh.2021.10.014
  • Coronavirus Disease-2019 (COVID-19) and the Liver. Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar Journal of Clinical and Translational Hepatology 2021;000(000):000–000. https://doi.org/10.14218/jcth.2021.00006
  • Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis. Swaroop S, Arora U, Biswas S, et al. J Clin Apheresis 2022;jca.22033. https://doi.org/10.1002/jca.22033
  • Incidence and Predictors of Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease. Shalimar, Sheikh SS, Biswas S, Vaishnav M et al. J Clin Exp Hepatol 2023;13(1):37–47. https://doi.org/10.1016/j.jceh.2022.09.007
  • Rapunzel Syndrome. Madhusudhan KS, Vaishnav M, Joy D. J Gastrointest Surg 2022;26(5):1111–2. https://doi.org/10.1007/s11605-021-05239
  • 15. Rapunzel Syndrome. Madhusudhan KS, Vaishnav M, Joy D. J Gastrointest Surg 2022;26(5):1111–2. https://doi.org/10.1007/s11605-021-05239-z
  • Clinical Utility of Transient Elastography in the Management of Patients with Budd-Chiari Syndrome Undergoing Endovascular Intervention. Anand A, Biswas S, Vaishnav M, et al J Vasc Interv Radiol 2022;33(3):268-277.e3. https://doi.org/10.1016/j.jvir.2021.11.003
  • Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria. Elhence A, Anand A, Biswas S, Vaishnav M et al. Dig Dis Sci https://doi.org/10.1007/s10620-022-07579-5
  • FibroScan–aspartate aminotransferase score in an Asian cohort of non‐alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery. Anand A, Elhence A, Vaishnav M, et al. J Gastroenterol Hepatol 2021;36(5):1309–16. https://doi.org/10.1111/jgh.15358
Training
  • MBBS: B.J. Medical college, Ahmedabad July 2009
  • MD (Internal Medicine): B.J. Medical college, Ahmedabad June 2015.
  • DM (Gastroenterology) Training: All India Institute of Medical Sciences (AIIMS), New Delhi July 2019
  • Fellowship in Hepatology: All India Institute of Medical Sciences (AIIMS), New Delhi July 2022
Awards And Achievements
  • Oral presentation at EASL Congress 2023, Vienna Austria
  • Oral presentation at ISGCON 2020 (Virtual conference)
  • Oral presentation at INASL 2023, Bhubaneshwar
  • Dr Rakesh Tandon Book prize for best AIIMS Delhi DM Gastroenterology student 2022